begin privacyenhanced message proctype micclear originatorname webmasterwwwsecgov originatorkeyasymmetric mfgwcgyevqgbaqicafdsgawrwjawsnkkavtbzyzmragjlwykxmzvdtinen twsmvrzladbmyqaionwgsdwpoamdtdezxmmztbtwidaqab micinfo rsamdrsa utyzmjlbkbtsiubgbzxxksgmoscwzrgorvlkzmgpeqrjcixls egllsnjzxmymig txt 20100325 hdrsgml 20100325 20100325171210 accession number 000095012310028292 conformed submission type da public document count filed date 20100325 date change 20100325 subject company company data company conformed name global med technology inc central index key 0001009463 standard industrial classification servicesprepackaged software 7372 irs number 841116894 state incorporation fiscal year end 1231 filing value form type da sec act 1934 act sec file number 00554591 film number 10705180 business address street 12600 colfax street suite c city lakewood state zip 80215 business phone 3032382000 mail address street 12600 west colfax avenue street suite c city lakewood state zip 801253737 former company former conformed name global data technology inc date name change 19960808 filed by company data company conformed name global med technology inc central index key 0001009463 standard industrial classification servicesprepackaged software 7372 irs number 841116894 state incorporation fiscal year end 1231 filing value form type da business address street 12600 colfax street suite c city lakewood state zip 80215 business phone 3032382000 mail address street 12600 west colfax avenue street suite c city lakewood state zip 801253737 former company former conformed name global data technology inc date name change 19960808 da gscdzahtm da scdza united state security exchange commission washington dc 20549 schedule d solicitationrecommendation statement section d security exchange act 1934 amendment no global med technology inc name subject company global med technology inc name person filing statement common stock par value 001 per share series convertible preferred stock par value 001 per share title class security e cusip number class security michael ruxin chief executive officer global med technology inc 12600 west colfax suite c lakewood 80215 303 2382000 name address telephone number person authorized receive notice communication behalf person filing statement copy to clayton parker martin schrier kl gate llp 200 biscayne boulevard suite 3900 miami florida 33131 305 5393300 check box filing relates solely preliminary communication made commencement tender offer amendment no solicitationrecommendation statement schedule d amends supplement solicitationrecommendation statement schedule d filed global med technology inc colorado corporation global med security exchange commission the sec march 2010 a amended supplemented time time schedule d schedule d relates offer haemonetics corporation massachusetts corporation haemonetics wholly owned subsidiary atlas acquisition corp colorado corporation purchaser purchase outstanding share global meds common stock 001 par value per share the global med common stock outstanding share global meds series convertible preferred stock 001 par value per share the global med preferred stock upon term subject condition set forth haemonetics offer purchase dated february 19 2010 a amended supplemented time time offer purchase offer purchase attached exhibit aa schedule filed haemonetics sec february 19 2010 a amended supplemented time time schedule to term offer a defined below set forth offer purchase related letter transmittal global med common stock letter transmittal global med preferred stock each context requires letter transmittal together offer purchase offer capitalized term used otherwise defined herein shall respective meaning ascribed term schedule d item schedule d hereby amended supplemented adding following immediately last paragraph on march 24 2010 connection expiration offer holder warrant the tendered warrants exercisable purchase aggregate 6535000 share global med common stock agreed tendered warrant would terminate immediately prior expiration offer exchange right receive lump sum cash payment equal product i excess a per share price global med common stock offer b per share exercise price applicable tendered warrant ii total number share global med common stock tendered warrant exercisable tendered warrant included warrant the victory park warrant purchase 4125000 share global med common stock exercise price 072 per share held victory park special situation master fund ltd termination victory park warrant tendered warrant documented letter agreement among applicable warrant holder haemonetics global med item schedule d hereby amended supplemented adding following immediately subheading entitled forward looking statements l expiration offer subsequent offering period 1200 midnight boston massachusetts time march 24 2010 offer expired based information provided computershare trust company na haemonetics expiration offer 3960 share global med preferred stock approximately 31428730 share global med common stock tendered withdrawn offer tendered share constituted 100 share global med preferred stock outstanding approximately 82 share global med common stock outstanding purchaser accepted payment share validly tendered properly withdrawn accordance term condition offer effective 900 am boston massachusetts time march 25 2010 haemonetics purchaser commenced subsequent offering period remaining untendered share global med common stock subsequent offering period expire 1200 midnight boston massachusetts time wednesday march 31 2010 unless extended extension followed public announcement later 900 am boston massachusetts time next business day subsequent offering period scheduled expire 122 per share common stock offer price net seller cash without interest le applicable withholding tax offered initial offering period paid subsequent offering period purchaser immediately accept payment share validly tendered subsequent offering period payment made promptly acceptance accordance term offer procedure tendering share subsequent offering period initial offering period except 1 share cannot delivered guaranteed delivery procedure 2 pursuant rule da promulgated exchange act share tendered subsequent offering period may withdrawn share validly tendered initial offering period may withdrawn subsequent offering period pursuant term merger agreement haemonetics acquisition global med completed merger purchaser global med following merger global med become wholly owned subsidiary haemonetics global med common stock longer eligible quotation otc bulletin board pursuant term merger agreement remaining publicly held global med common stock other global med common stock held holder validly exercise perfect dissenters right applicable colorado law acquired 122 per share global med common stock net holder cash without interest le applicable withholding tax merger end subsequent offering period purchaser may exercise topup option purchase topup option share global med purchaser 90 outstanding global med common stock purchaser becomes owner 90 outstanding global med common stock subsequent offering period andor exercise topup option merger completed accordance applicable provision colorado law authorize completion merger without vote meeting stockholder global med march 25 2010 haemonetics purchaser issued press release announcing expiration offer commencement subsequent offering period full text press release issued haemonetics purchaser set forth exhibit a hereto incorporated herein reference item schedule d hereby amended supplemented changing subheading entitled l forwardlooking statements reflect following m forwardlooking statements item schedule d hereby amended supplemented adding following a press release issued haemonetics purchaser dated march 25 2010 incorporated reference exhibit ac amendment no schedule to signature due inquiry best knowledge belief certify information set forth statement true complete correct global med technology inc by s michael ruxin md name michael ruxin md title chief executive officer dated march 25 2010 end privacyenhanced message